Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mark

Showing results (151-160 of 1,657) with videos related to

Pageof 166
Sort By:
American Heart Journal|April 30, 1999
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Use of abciximab: comparative economic dataD B Mark, T A Simons
The American Journal of Managed Care|July 6, 1997
Quality improvement and clinical research: an important partnershipJ G Jollis, D B Mark
Circulation|July 31, 2002
Medical economics and the assessment of value in cardiovascular medicine: Part IIDaniel B Mark, Mark A Hlatky
Anesthesia and Analgesia|July 1, 1983
Intraoperative awareness and hypertensive crisis during high-dose fentanyl-diazepam-oxygen anesthesiaJ B Mark, L M Greenberg
Archives of Surgery (Chicago, Ill. : 1960)|January 1, 1980
Esophageal leiomyoma first seen as a superior mediastinal massW A Baumgartner, J B Mark
Lancet (London, England)|June 24, 2008
Laquinimod, a new oral drug for multiple sclerosisB Mark Keegan, Brian G Weinshenker
The New England Journal of Medicine|February 13, 2004
B-type natriuretic peptide - a biomarker for all seasons?Daniel B Mark, G Michael Felker
The Journal of ECT|September 7, 2007
Electroconvulsive therapy in patients with multiple sclerosisKeith G Rasmussen, B Mark Keegan
The Annals of Thoracic Surgery|March 1, 1997
Postthoracoscopy pain: is TENS the answer?J B Brodsky, J B Mark
Heart Failure Clinics|November 22, 2012
The economics of heart failureDhruv S Kazi, Daniel B Mark
Pageof 166

Showing results (151-160 of 1,657) with videos related to

Sort By:
Pageof 166
American Heart Journal|April 30, 1999
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Use of abciximab: comparative economic dataD B Mark, T A Simons
The American Journal of Managed Care|July 6, 1997
Quality improvement and clinical research: an important partnershipJ G Jollis, D B Mark
Circulation|July 31, 2002
Medical economics and the assessment of value in cardiovascular medicine: Part IIDaniel B Mark, Mark A Hlatky
Anesthesia and Analgesia|July 1, 1983
Intraoperative awareness and hypertensive crisis during high-dose fentanyl-diazepam-oxygen anesthesiaJ B Mark, L M Greenberg
Archives of Surgery (Chicago, Ill. : 1960)|January 1, 1980
Esophageal leiomyoma first seen as a superior mediastinal massW A Baumgartner, J B Mark
Lancet (London, England)|June 24, 2008
Laquinimod, a new oral drug for multiple sclerosisB Mark Keegan, Brian G Weinshenker
The New England Journal of Medicine|February 13, 2004
B-type natriuretic peptide - a biomarker for all seasons?Daniel B Mark, G Michael Felker
The Journal of ECT|September 7, 2007
Electroconvulsive therapy in patients with multiple sclerosisKeith G Rasmussen, B Mark Keegan
The Annals of Thoracic Surgery|March 1, 1997
Postthoracoscopy pain: is TENS the answer?J B Brodsky, J B Mark
Heart Failure Clinics|November 22, 2012
The economics of heart failureDhruv S Kazi, Daniel B Mark
Pageof 166